Five ways to tackle toxicity (or the ant, the spider, and the bee). 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. October 25-28, 2004, Washington, DC.
Mascolini
Mark
M
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D004334:Drug Administration Schedule; D013006:Growth Hormone / Q000009:adverse effects / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects; D007333:Insulin Resistance; D008060:Lipodystrophy / Q000139:chemically induced / Q000188:drug therapy; D010024:Osteoporosis / Q000150:complications; D014529:Uridine / Q000008:administration & dosage
D019380:Anti-HIV Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D013006:Growth Hormone; D002784:Cholesterol; D014529:Uridine